Comments

Aprea Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Aprea Therapeutics (APRE) operate in?

Aprea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

APRENASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$1.67

0.010.60%

At close: -

$1.74

0.074.17%

After Hours: May 22, 7:09 PM EDT

Aprea Therapeutics (APRE) Forecast

News Earnings Aprea Therapeutics (APRE) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Aprea Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:APRE | Benzinga

Explore Aprea Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for APRE.

Open	$1.65
Close	$1.67
Volume / Avg.	8.03K / 25.30K
Day Range	$1.61 - $1.68
52 Wk Range	1.41 - 5.30
Market Cap	$9.24M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	1.23%
Days to Cover	3.07

Recent News

Why Is Precision Oncology-Focused Aprea Therapeutics Stock Trading Higher On Monday?

FDA clearance for Aprea Therapeutics' APR-1051 IND application, a promising WEE1 kinase inhibitor. Phase 1 trial initiation in 2024, focusing on Cyclin E cancers. $34 million private placement to fund clinical development and ensure company sustainability until 2026.

Vandana Singh

Satsuma Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying

The Dow Jones closed higher by over 160 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Why Aprea Therapeutics Shares Hit A New 52-Week Low Today

Aprea Therapeutics Inc (NASDAQ: APRE) shares are trading lower by 17.59% to $5.20 after the company announced pricing of a $5.5 million underwritten public offering of common stock. What Else?

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.65
Close	$1.67
Volume / Avg.	8.03K / 25.30K
Day Range	$1.61 - $1.68
52 Wk Range	1.41 - 5.30
Market Cap	$9.24M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	1.23%
Days to Cover	3.07

About Aprea Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precis...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Aprea Therapeutics (APRE) stock?

You can purchase shares of Aprea Therapeutics (NASDAQ:APRE) through any online brokerage.

View our list of the best stock brokerages

Who are Aprea Therapeutics (APRE) competitors?

Other companies in Aprea Therapeutics’s space includes: Immuron (NASDAQ:IMRN), Acurx Pharmaceuticals (NASDAQ:ACXP), Cellectar Biosciences (NASDAQ:CLRB), CARISMA Therapeutics (NASDAQ:CARM) and Evaxion (NASDAQ:EVAX).

What is the forecast, or price target, for Aprea Therapeutics (APRE) stock?

Aprea Therapeutics has a consensus price target of $15.67.

What is the current price for Aprea Therapeutics (APRE)?

The stock price for Aprea Therapeutics (NASDAQ: APRE) is $1.67 last updated May 23, 2025 at 4:00 PM EDT.

Does Aprea Therapeutics (APRE) pay a dividend?

There are no upcoming dividends for Aprea Therapeutics.

When is Aprea Therapeutics (NASDAQ:APRE) reporting earnings?

Aprea Therapeutics’s Q2 earnings are confirmed for Monday, August 11, 2025.

Is Aprea Therapeutics (APRE) going to split?

There is no upcoming split for Aprea Therapeutics.

What sector and industry does Aprea Therapeutics (APRE) operate in?

Aprea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.